Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL28492208 | 0.73 | MAPK1 (0.37) | MAPK1CA4ALDH1A1ALOX15CA12 | |
| SCHEMBL28129819 | 0.70 | MAPK1 (0.34) | MAPK1CA4ALDH1A1ALOX15 | |
| SCHEMBL2989193 | 0.69 | CA4 (0.41) | MAPK1CA4ALDH1A1CA12CA1 | |
| SCHEMBL1658642 | 0.69 | CA4 (0.41) | MAPK1CA4ALDH1A1CA12CA1 | |
| SCHEMBL18397 | 0.69 | MAPK1 (0.36) | MAPK1ALDH1A1ALOX15KCNN4 | |
| SCHEMBL3691009 | 0.69 | MAPK1 (0.36) | MAPK1ALDH1A1ALOX15KCNN4 | |
| SCHEMBL991780 | 0.69 | CA4 (0.41) | MAPK1CA4ALDH1A1CA12CA1 | |
| SCHEMBL1795093 | 0.68 | MAPK1 (0.33) | MAPK1CA4ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL22288246 | 0.67 | MAPK1 (0.35) | MAPK1ALDH1A1ALOX15 | |
| SCHEMBL6941189 | 0.67 | MAPK1 (0.35) | MAPK1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4537 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | claimed |
| US-20230406878-A1 | OLIGONUCLEOTIDES, REAGENTS, AND PREPARATION THEREOF | BIOGEN MA INC. | 2023-12-21 | — | — | US | claimed |
| CN-116940582-A | Oligonucleotides, reagents and their preparation | 渤健马萨诸塞州股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| CN-116284162-A | Synthesis and preparation method of lycium barbarum acid | 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） | 2023-06-23 | — | — | CN | claimed |
| WO-2023070009-A1 | SILYL ETHER DERIVATIVES OF POLYETHER POLYMERS | P2 SCIENCE, INC. (US) | 2023-04-27 | — | — | WO | claimed |
| EP-3649135-B1 | SYNTHESIS OF HALICHONDRINS | HARVARD COLLEGE (US) | 2022-12-28 | — | — | EP | claimed |
| US-20220387957-A1 | MICROWAVE-ASSISTED METHOD FOR SYNTHESIS OF OLIGO- AND POLYSACCHARIDES ON SOLID PHASE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-12-08 | — | — | US | claimed |
| US-11241435-B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| US-5144028-A | Antibiotics | MERCK & CO., INC. (US) | 1992-09-01 | — | — | US | claimed |
| US-5132421-A | 2-naphthyl-carbapenem intermediates | MERCK & CO., INC. (US) | 1992-07-21 | — | — | US | claimed |
| US-5132420-A | INTERMEDIATES FOR PREPARING 2-(SUBSTITUTED-DIBENZO-FURANYL AND DIBENZOTHIENYL) CARBAPENEM ANTIBACTERIAL AGENTS | MERCK & CO., INC. (US) | 1992-07-21 | — | — | US | claimed |
| US-5132422-A | 2-naphthyl-carbapenem intermediates | MERCK & CO., INC. (US) | 1992-07-21 | — | — | US | claimed |
| EP-0480715-A1 | Intermediates for preparing 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | claimed |
| EP-0480712-A1 | 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | claimed |
| EP-0303562-B1 | Process for the preparation of E/Z mixtures of 2-(bicyclo[3.3.0]octan-3-ylidene) acetic-acid derivatives with a major proportion of E or Z isomer | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-01-15 | — | — | EP | claimed |
| EP-0465126-A2 | Carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-01-08 | — | — | EP | claimed |
| WO-1989001470-A1 | PROCESS FOR PRODUCING E/Z MIXTURES OF 2-(BICYCLO[3.3.0]OCTANE-3-YLIDENE) ACETIC ACID DERIVATIVES WITH PREDOMINANT E OR Z MOIETIES | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1989-02-23 | — | — | WO | claimed |
| EP-0303562-A1 | Process for the preparation of E/Z mixtures of 2-(bicyclo[3.3.0]octan-3-ylidene) acetic-acid derivatives with a major proportion of E or Z isomer | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-02-15 | — | — | EP | claimed |